$1.25 -0.02 (-1.57%)

MIRA Pharmaceuticals, Inc. Common Stock (MIRA)

MIRA Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for neurological and psychiatric disorders. The company aims to address unmet medical needs through its research-driven pipeline, utilizing novel drug delivery systems and targeted treatments.

Company News

Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

GlobeNewswire Inc. • Delveinsight • August 12, 2025

Over 50 companies are advancing cannabinoid drug research, exploring potential treatments for mental health disorders, neurodegenerative diseases, and chronic inflammation, with promising clinical trials targeting conditions like Alzheimer's, pain management, and epilepsy.

IGC SPRC

EXCLUSIVE: Mira Pharmaceuticals Board Approves SKNY Pharma Acquisition, Establishing Combined Enterprise Value Over $60 Million

Benzinga • Vandana Singh • May 8, 2025

Mira Pharmaceuticals has approved the acquisition of SKNY Pharmaceuticals, creating a combined enterprise value of over $60 million. The deal is expected to bring together the companies' pipelines and market opportunities.

Stocks To Watch: Eyes On Treasury Yields, China EV Names, And Lululemon

Seeking Alpha • SA Stocks To Watch • August 26, 2023

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week

CRM VZ BVFL CTNT